Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

Boehringer Ingelheim

Status: Completed

Conditions: Parkinson Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00613301

248.549

Details and patient eligibility

About

The survey is conducted to collect safety and effectiveness information in Parkinson's Disease patients treated with Pramipexole without concomitant L-Dopa supplementation in the daily clinical settings in Japan.

Enrollment: 416 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients with Parkinson's disease who do not receive L-Dopa supplementation

Exclusion criteria

Patients should have been treated according to the Japanese insert slip